Angiogenic growth factors in maternal and fetal serum in pregnancies complicated with intrauterine growth restriction

Journal of Obstetrics and Gynaecology

Volumn 34, Issue 3, 2014, Pages 218-220

  Borras, D ^a   Perales Puchalt, A ^a   Ruiz Sacedon N ^b   Perales, A ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Angiogenesis; Fetal growth restriction; SFlt 1; VEGF

Indexed keywords

ANGIOGENIC FACTOR; GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; FLT1 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; HUMAN; INTRAUTERINE GROWTH RETARDATION; MALE; MATERNAL PLASMA; MATERNAL SERUM; PREGNANCY; PRIORITY JOURNAL; UMBILICAL ARTERY; UMBILICAL CORD; BLOOD; CASE CONTROL STUDY; CHEMISTRY; FETUS BLOOD; PROSPECTIVE STUDY;

ADULT; CASE-CONTROL STUDIES; FEMALE; FETAL BLOOD; FETAL GROWTH RETARDATION; HUMANS; PREGNANCY; PROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84897071026     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2013.834304     Document Type: Article

References (8)

1. Figueras F, Gardosi J. 2011. Intrauterine growThrestriction: New concepts in antenatal surveillance, diagnosis, and management. American Journal of Obstetrics and Gynecology 204: 288-300
2. Gourvas V, Dalpa E, Konstantinidou A, Vrachnis N, Spandidos DA, Sifakis S. 2012. Angiogenic factors in placentas from pregnancies complicated by fetal growThrestriction. Molecular Medicine Reports 6: 23-27
3. Jacobs M, Nassar N, Roberts CL, Hadfi eld R, Morris JM, Ashton AW. 2011. Levels of soluble fms-like tyrosine kinase one in fi rst trimester and outcomes of pregnancy: A systematic review. Reproductive Biology and Endocrinology 9: 77
4. Kendall RL, Thomas KA. 1993. Inhibition of vascular endothelial cell growThfactor activity by an endogenously encoded soluble receptor. Proceedings of the National Academy of Sciences of the United States of America 90: 10705-10709
5. Maulik D, Frances Evans J, Ragolia L. 2006. Fetal growThrestriction: Pathogenic mechanisms. Clinical Obstetrics and Gynecology 49: 219-227
6. Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH. 2006. Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growThfactor in women withabnormal uterine artery Doppler and in those withfetal growThrestriction. American Journal of Obstetrics and Gynecology 195: 1668-1673
7. Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW et al. 2007. Angiogenic growThfactors in maternal and fetal serum in pregnancies complicated by intrauterine growThrestriction. Clinical Science 112: 51-57
8. Wathen KA, Tuutti E, Stenman UH, Alft han H, Halmesmaki E, Finne P et al. 2006. Maternal serum-soluble vascular endothelial growThfactor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growThretardation. Journal of Clinical Endocrinology and Metabolism 91: 180-184